Join Now
Why Join?
Log In
Your Username/Email:
Your Password:
Remember Me
Forgot your password?
or
Home
Stocks
ETFs
Futures
Forex
Funds
Economy
Education
My Barchart
Market Pulse
Indices
Signals
Hot Stocks
Sectors
Portfolio Blogs
News & Commentary
Stock Screener
Enter ticker symbol
Extended Search
Symbol Search
Select a Commodity
--Grains and Oilseeds--
Wheat
Corn
Soybeans
Soybean Meal
Soybean Oil
Oats
Rough Rice
KCBT Wheat
Spring Wheat
Canola
--Currencies--
U.S. Dollar Index
British Pound
Canadian Dollar
Japanese Yen
Swiss Franc
Euro FX
Australian Dollar
Mexican Peso
--Energies--
Crude Oil
Heating Oil
Gasoline RBOB
Natural Gas
Ethanol
--Financials--
30 Year T-Bond
10 Year T-Note
5 Year T-Note
2 Year T-Note
10-Year Swaps
5-Year Swaps
30 Day Fed Funds
Eurodollar
--Indices--
S&P 500 Index
E-Mini S&P 500
Nasdaq 100
E-Mini Nasdaq
Dow Industrials
E-Mini Dow
NYSE Composite
S&P Midcap 400
E-Mini S&P Midcap
E-Mini Russell 2000
E-Mini SmallCap 600
CRB CCI Index
--Meats--
Live Cattle
Feeder Cattle
Lean Hogs
Pork Bellies
CME Milk
--Metals--
Gold
Silver
High Grade Copper
Platinum
Palladium
NYSE Gold
NYSE Silver
--Softs--
Cotton #2
Orange Juice
Coffee
Sugar #11
Cocoa
Sugar #16
Lumber
or enter GC* - Gold Futures
Quotes and Charts
Quote
Detailed Quote
Options Quotes
Technical Chart
Interactive Chart
Technical Analysis
Technical Analysis
Trader's Cheat Sheet™
Barchart Opinions
Barchart Opinion
Snapshot Opinion
Trading Strategies
Company Info
News Headlines
Profile
Key Statistics
Earnings
Analyst Ratings
Ratios
Income Statement
Balance Sheet
YOU ARE HERE:
Stocks
» Quotes and Charts » Quote
Symbols:
Top Stocks
Futures Markets
My Stocks
Save
Cancel
+ Portfolio
Apricus Biosciences Inc (APRI)
2.75
-0.03 (-1.08%)
3:59P EST
(NASDAQ)
Stock Price Quote as of
Thursday, May 24th, 2012
High
2.80
Low
2.72
52Wk High
5.94
Since 01/09/12
(-53.70%)
52Wk Low
2.34
Since 05/04/12
(+17.52%)
Open
2.76
Prev Close
2.78
Volume
55,832
Avg Volume
137,502
EPS
-0.72
Div & Yield
N/A
P/E Ratio
0.00
Market Cap
$72.93 M
Weighted Alpha
-43.40
Standard Dev
+0.49
Sectors
Medical - Drugs
,
All APRI Sectors
View Detailed Quote
Chart Snapshot
Customize Chart
Barchart Opinion
View Opinion
Strong Buy
Buy
Hold
Sell
Strong Sell
Support & Resistance
Get Cheat Sheet
2nd Resistance Point
2.85
1st Resistance Point
2.81
Last Price
2.75
1st Support Level
2.73
2nd Support Level
2.69
Latest Headlines
More Headlines
Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for the Treatment of Onychomycosis
GlobeNewswire - Tue May 22, 9:13AM CDT
8-K: APRICUS BIOSCIENCES, INC.
Edgar Online - Mon May 21, 8:51AM CDT
Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) for the Treatment of Female Sexual Arousal Disorder
GlobeNewswire - Mon May 21, 8:35AM CDT
BUYINS.NET: GRVY, APRI, ALTE, IDRA, NM, FMCN Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Fri May 18, 7:22AM CDT
Apricus Biosciences to Present at the 11th Annual JMP Securities Research Conference
GlobeNewswire - Mon May 14, 8:42AM CDT
Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) for the Treatment of Onychomycosis
GlobeNewswire - Fri May 11, 8:55AM CDT
10-Q: APRICUS BIOSCIENCES, INC.
Edgar Online - Thu May 10, 2:42PM CDT
Apricus Biosciences Announces First Quarter 2012 Financial Results Conference Call and Provides Corporate Update
GlobeNewswire - Tue May 08, 8:49AM CDT
Health Canada Grants Apricus Biosciences Pre-NDS Meeting for Femprox for Female Sexual Arousal Disorder
GlobeNewswire - Mon May 07, 9:10AM CDT
Apricus Biosciences Announces Poster Presentation of Femprox(R) Phase III Clinical Data at American Urological Association Annual Meeting
GlobeNewswire - Fri May 04, 9:05AM CDT